DCC-2812

N/A

Report date: 2025/05/30 14:54:10
NME

Base Information

Drug NameDCC-2812
Drug Alias NameDCC-2812
ClassificationOther
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 activators
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantCarcinoma, Transitional CellCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDeciphera Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesDeciphera Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantCarcinoma, Transitional CellCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A